Avidity Biosciences (RNAM) Fails to deliver data

Key failure to deliver metrics for Avidity Biosciences:

• Last SEC data release: 2024-06-14
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: N/A
• Last 12 months FTD volume: A$21.9 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Avidity Biosciences (RNAM) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Avidity Biosciences (RNAM) - since 2020

Avidity Biosciences (RNAM) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Pfizer PFE	A$38.26 M	A$0.34 B	🇺🇸 USA
GSK plc GSK	A$54.15 M	A$0.19 B	🇬🇧 UK
Sarepta Therapeutics SRPT	A$3.75 M	A$22.89 M	🇺🇸 USA
PTC Therapeutics PTCT	A$33.3 M	A$63.96 M	🇺🇸 USA
Fate Therapeutics FATE	A$0.11 M	A$1.12 M	🇺🇸 USA
Acorda Therapeutics ACOR	N/A	A$0.01 M	🇺🇸 USA
Catalyst Pharmaceuticals CPRX	A$0 M	A$23.22 M	🇺🇸 USA